n(1)-methylnicotinamide has been researched along with Rosacea in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Rosacea: A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rosacea is a chronic facial dermatosis with a progressive course, which is characterized by the presence of erythema, papules, pustules, telangiectasias and sebaceous gland hyperplasia." | 1.33 | Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. ( Gebicki, J; Sysa-Jedrzejowska, A; Wieczorkowska, M; Wozniacka, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wozniacka, A | 1 |
| Wieczorkowska, M | 1 |
| Gebicki, J | 1 |
| Sysa-Jedrzejowska, A | 1 |
1 other study available for n(1)-methylnicotinamide and Rosacea
| Article | Year |
|---|---|
Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study.
Topics: Administration, Topical; Adult; Chronic Disease; Dermatologic Agents; Facial Dermatoses; Female; Gel | 2005 |